Published in Ann Surg Oncol on December 01, 2011
Trends in esophageal adenocarcinoma incidence and mortality. Cancer (2012) 2.03
Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer (2013) 1.25
Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg (2013) 0.88
Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol (2016) 0.80
MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study. Clin Transl Gastroenterol (2014) 0.80
Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction. Am J Cancer Res (2016) 0.79
Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients. Surg Endosc (2015) 0.77
Retrospective study using the propensity score to clarify the oncologic feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg (2013) 0.76
Early onset esophageal adenocarcinoma: a distinct molecular entity? Oncoscience (2016) 0.75
Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med (2008) 8.88
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res (2005) 5.16
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol (2002) 5.10
Evolving options in the management of esophageal perforation. Ann Thorac Surg (2004) 4.12
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med (2008) 3.48
Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg (2007) 2.73
Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. Ann Thorac Surg (2002) 2.15
Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg (2003) 2.05
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology (2014) 1.91
Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer (2009) 1.90
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res (2005) 1.86
Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer (2008) 1.82
Current management of esophageal leiomyoma. J Am Coll Surg (2004) 1.82
Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center. Cancer (2002) 1.81
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors. J Clin Oncol (2004) 1.67
The value of high-resolution manometry in the assessment of the resting characteristics of the lower esophageal sphincter. J Gastrointest Surg (2009) 1.66
Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol Ther (2003) 1.65
Ethnic differences among patients with cutaneous melanoma. Arch Intern Med (2006) 1.63
Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg (2009) 1.63
Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer (2009) 1.55
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer (2008) 1.53
Outcomes after 151 extended transcervical thymectomies for myasthenia gravis. Ann Thorac Surg (2006) 1.49
Benign expectoration of a surgical clip through a pneumonectomy stump. J Thorac Cardiovasc Surg (2002) 1.48
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res (2007) 1.47
Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg (2004) 1.46
Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease. J Appl Physiol (1985) (2006) 1.45
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy. Clin Cancer Res (2010) 1.44
Catamenial pneumothorax: optimal hormonal and surgical management. Eur J Cardiothorac Surg (2005) 1.42
WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res (2003) 1.42
Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy. Cancer Res (2008) 1.38
Giant bullous lung disease: evaluation, selection, techniques, and outcomes. Chest Surg Clin N Am (2003) 1.37
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. Int J Cancer (2008) 1.34
Pneumomediastinum: etiology and a guide to diagnosis and treatment. Am J Surg (2013) 1.34
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers. Clin Cancer Res (2008) 1.32
Metastatic renal cell carcinoma to the nose and ethmoid sinus. Urology (2006) 1.30
Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement. Cancer Epidemiol Biomarkers Prev (2011) 1.27
Recurrence after esophagectomy for adenocarcinoma: defining optimal follow-up intervals and testing. J Am Coll Surg (2010) 1.27
Postoperative mortality after esophagectomy for cancer: development of a preoperative risk prediction model. Ann Surg Oncol (2008) 1.27
Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res (2005) 1.26
The effect of diabetes combined with stroke on disability, self-rated health, and mortality in older Mexican Americans: results from the Hispanic EPESE. Arch Phys Med Rehabil (2003) 1.23
Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer (2009) 1.20
Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecol Oncol (2006) 1.19
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res (2005) 1.19
Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg (2009) 1.18
Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Med Oncol (2010) 1.16
Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol (2006) 1.16
Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. Am J Respir Crit Care Med (2010) 1.16
Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol (2011) 1.14
Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res (2004) 1.13
Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol (2002) 1.13
Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol (2005) 1.12
Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol (2005) 1.12
A multilevel analysis of socioeconomic status and prostate cancer risk. Ann Epidemiol (2006) 1.12
Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med (2008) 1.12
Long-term pain and activity during recovery from major thoracotomy using thoracic epidural analgesia. Anesthesiology (2002) 1.12
Comparative study of subxiphoid versus video-thoracoscopic pericardial "window". Ann Thorac Surg (2005) 1.11
A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma. Clin Cancer Res (2007) 1.10
Gene expression profiling of malignant mesothelioma. Clin Cancer Res (2003) 1.10
Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med (2003) 1.10
Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis. Mod Pathol (2011) 1.09
Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report. Am J Respir Crit Care Med (2010) 1.09
Current presentation and optimal surgical management of sternoclavicular joint infections. Ann Thorac Surg (2002) 1.07
B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. J Immunother (2008) 1.07
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res (2003) 1.07
Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. J Thorac Cardiovasc Surg (2004) 1.05
Should asymptomatic enlarged thymus glands be resected? J Thorac Cardiovasc Surg (2010) 1.04
Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer (2008) 1.04
Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy. Cancer Res (2003) 1.04
Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg (2009) 1.03
Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer (2010) 1.03
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Canc Netw (2009) 1.03
Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol (2008) 1.03
Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity. Clin Cancer Res (2004) 1.02
Suction vs water seal after pulmonary resection: a randomized prospective study. Chest (2002) 1.01
Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer. J Surg Oncol (2008) 1.01
Surgeon contribution to hospital bottom line: not all are created equal. Ann Surg (2005) 1.00
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther (2003) 1.00
Clinical and magnetic resonance imaging-based outcomes to 5 years after matrix-induced autologous chondrocyte implantation to address articular cartilage defects in the knee. Am J Sports Med (2011) 1.00
Thoracic surgery workforce: snapshot at the end of the twentieth century and implications for the new millennium. Ann Thorac Surg (2002) 1.00
Outcomes of acute type a aortic dissection after previous cardiac surgery. Ann Thorac Surg (2010) 0.99
Pain and physical function are similar following axillary, muscle-sparing vs posterolateral thoracotomy. Chest (2005) 0.99
Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res (2003) 0.99
Post-treatment surveillance in a large cohort of patients with colon cancer. Am J Manag Care (2011) 0.98
Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas. Cancer (2010) 0.98
Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer (2009) 0.98
Stress ulcer prophylaxis for non-critically ill patients on a teaching service. J Eval Clin Pract (2007) 0.97
The role of caveolin-1 in androgen insensitive prostate cancer. J Urol (2002) 0.97
Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer (2010) 0.96
Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis. Clin Vaccine Immunol (2007) 0.95
Detection of gastric conduit ischemia or anastomotic breakdown after cervical esophagogastrostomy: the use of computed tomography scan versus early endoscopy. Surg Endosc (2010) 0.95
Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis. Am J Med Sci (2011) 0.95
Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc (2008) 0.94
Microarray data simulator for improved selection of differentially expressed genes. Cancer Biol Ther (2003) 0.94
Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer (2011) 0.93